The total number of records retrieved from this search are 12. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_1302	Virus nameAdenovirus	Virus strainOBP-301	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman prostate cancer cell line	Cell linePrEC	Concentration of cell line1000 cells per well	In-vitro toxicityNA	AssayCell proliferation kit by Roche Diagnostics	In-vitro virus concentration0.1 MOI	In-vitro resultNo significant effect on cell death after day 1	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID18274558
IDOV_1303	Virus nameAdenovirus	Virus strainOBP-301	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman prostate cancer cell line	Cell linePrEC	Concentration of cell line1000 cells per well	In-vitro toxicityNA	AssayCell proliferation kit by Roche Diagnostics	In-vitro virus concentration0.1 MOI	In-vitro resultNo significant effect on cell death after day 2	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID18274558
IDOV_1304	Virus nameAdenovirus	Virus strainOBP-301	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman prostate cancer cell line	Cell linePrEC	Concentration of cell line1000 cells per well	In-vitro toxicityNA	AssayCell proliferation kit by Roche Diagnostics	In-vitro virus concentration0.1 MOI	In-vitro resultNo significant effect on cell death after day 3	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID18274558
IDOV_1305	Virus nameAdenovirus	Virus strainOBP-301	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman prostate cancer cell line	Cell linePrEC	Concentration of cell line1000 cells per well	In-vitro toxicityNA	AssayCell proliferation kit by Roche Diagnostics	In-vitro virus concentration0.1 MOI	In-vitro resultNo significant effect on cell death after day 4	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID18274558
IDOV_1306	Virus nameAdenovirus	Virus strainOBP-301	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman prostate cancer cell line	Cell linePrEC	Concentration of cell line1000 cells per well	In-vitro toxicityNA	AssayCell proliferation kit by Roche Diagnostics	In-vitro virus concentration1 MOI	In-vitro resultNo significant effect on cell death after day 1	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID18274558
IDOV_1307	Virus nameAdenovirus	Virus strainOBP-301	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman prostate cancer cell line	Cell linePrEC	Concentration of cell line1000 cells per well	In-vitro toxicityNA	AssayCell proliferation kit by Roche Diagnostics	In-vitro virus concentration1 MOI	In-vitro resultNo significant effect on cell death after day 2	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID18274558
IDOV_1308	Virus nameAdenovirus	Virus strainOBP-301	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman prostate cancer cell line	Cell linePrEC	Concentration of cell line1000 cells per well	In-vitro toxicityNA	AssayCell proliferation kit by Roche Diagnostics	In-vitro virus concentration1 MOI	In-vitro resultNo significant effect on cell death after day 3	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID18274558
IDOV_1309	Virus nameAdenovirus	Virus strainOBP-301	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman prostate cancer cell line	Cell linePrEC	Concentration of cell line1000 cells per well	In-vitro toxicityNA	AssayCell proliferation kit by Roche Diagnostics	In-vitro virus concentration1 MOI	In-vitro resultNo significant effect on cell death after day 4	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID18274558
IDOV_1310	Virus nameAdenovirus	Virus strainOBP-301	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman prostate cancer cell line	Cell linePrEC	Concentration of cell line1000 cells per well	In-vitro toxicityNA	AssayCell proliferation kit by Roche Diagnostics	In-vitro virus concentration10 MOI	In-vitro resultNo significant effect on cell death after day 1	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID18274558
IDOV_1311	Virus nameAdenovirus	Virus strainOBP-301	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman prostate cancer cell line	Cell linePrEC	Concentration of cell line1000 cells per well	In-vitro toxicityNA	AssayCell proliferation kit by Roche Diagnostics	In-vitro virus concentration10 MOI	In-vitro resultNo significant effect on cell death after day 2	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID18274558
IDOV_1312	Virus nameAdenovirus	Virus strainOBP-301	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman prostate cancer cell line	Cell linePrEC	Concentration of cell line1000 cells per well	In-vitro toxicityNA	AssayCell proliferation kit by Roche Diagnostics	In-vitro virus concentration10 MOI	In-vitro resultNo significant effect on cell death after day 3	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID18274558
IDOV_1313	Virus nameAdenovirus	Virus strainOBP-301	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationNone	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineATCC	Origin of cell lineHuman prostate cancer cell line	Cell linePrEC	Concentration of cell line1000 cells per well	In-vitro toxicityNA	AssayCell proliferation kit by Roche Diagnostics	In-vitro virus concentration10 MOI	In-vitro resultNo significant effect on cell death after day 4	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID18274558